CERN Cerner Corporation

Cerner Names New Chief Financial Officer

Cerner Names New Chief Financial Officer

Mark Erceg Brings Multi-Dimensional Experience to Health Care Technology Leader

KANSAS CITY, Mo., Jan. 21, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global health care technology company, announced today that Mark Erceg will join the company as Executive Vice President and Chief Financial Officer (CFO), effective February 22, 2021. Erceg will succeed Marc Naughton, who is departing from Cerner at the end of the first quarter. Naughton will serve as an Executive Advisor to ensure a smooth transition.

Erceg comes to Cerner with more than 25 years of multi-dimensional financial experience, including serving as CFO at three different publicly-held companies. He began his career at Procter & Gamble and spent more than 18 years in a variety of finance, strategy and operational leadership roles. After leaving P&G, Erceg had three successive CFO roles at Masonite International Corporation, Canadian Pacific Railway and Tiffany & Company, where he has developed deep functional expertise and technical knowledge in all aspects of corporate finance. During his career, he has demonstrated the ability to create shareholder value at multi-billion-dollar organizations by leading operational transformation initiatives across complex global businesses, developing and executing strategic plans and negotiating and integrating acquisitions. Erceg holds a Bachelor of Science in Accounting, an MBA in Finance from Indiana University and is a Chartered Financial Analyst.

“I am pleased to welcome Mark to Cerner’s executive team,” said Brent Shafer, chairman and CEO, Cerner. “Mark’s diverse skill set and deep experience in global and operational finance is an excellent fit as Cerner continues to transform and innovate for worldwide providers and health care systems. I am confident Mark will provide strong leadership and be a terrific fit within Cerner.”

As Cerner’s CFO, Erceg will lead the company’s global finance organization, including accounting, treasury, financial planning and analysis, tax and investor relations.

“I am thrilled to join Cerner and work towards the company’s mission of transforming health care,” said Erceg. “Cerner is well-positioned to deliver innovations that can improve patient care, enhance health system operations and eliminate global inequities in care. I look forward to helping drive the next wave of growth and unlocking value for Cerner shareholders.”

Last October, Cerner announced that long-time CFO Marc Naughton would leave the company after 30 years.

About Cerner

’s health technologies connect people and information systems at thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit ,  or connect on , , ,  or . Nasdaq: CERN. Health care is too important to stay the same.

Media Contacts:

Cerner

Misti Preston, Director of Public Relations,



EN
21/01/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cerner Corporation

CERNER sees an upgrade to Slightly Positive due to a better fundamenta...

The general evaluation of CERNER (US), a company active in the Software industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date December 14, 2021, the closing price was USD 77.26 and...

 PRESS RELEASE

Cerner Announces Increased Quarterly Dividend

Cerner Announces Increased Quarterly Dividend Dividend of $0.27 per issued and outstanding share reflects 23% increase KANSAS CITY, Mo., Dec. 10, 2021 (GLOBE NEWSWIRE) --  (NASDAQ: CERN), a global healthcare technology company, today announced that its board of directors declared a cash dividend to stockholders of $0.27 per issued and outstanding share, up 23 percent from the prior quarterly dividend of $0.22. The cash dividend will be payable January 11, 2022, to shareholders of record as of the close of business December 27, 2021. Cerner intends to pay regular quarterly cash dividend...

 PRESS RELEASE

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Offic...

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Officer Experienced Clinical Executive to Lead Patient and Caregiver Experiences KANSAS CITY, Mo., Nov. 16, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, today announced Nasim Afsar, MD, MBA, MHM, as the company’s first Chief Health Officer, effective January 2022. In this new role, Dr. Afsar will lead Cerner’s more than 1,000 healthcare professionals who provide insight and guidance to product development and improving the lives of patients and caregivers. She will also lead the quality...

 PRESS RELEASE

Cerner Reports Third Quarter 2021 Results

Cerner Reports Third Quarter 2021 Results Delivers Strong Results Across Key MetricsGAAP Operating Margin and Diluted EPS Lower; Adjusted Operating Margin and Adjusted Diluted EPS Both up Sharply vs. Year-Ago QuarterFull-Year Guidance Increased KANSAS CITY, Mo., Oct. 29, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: CERN) today announced results for the 2021 third quarter that ended September 30, 2021. The third quarter 2021 earnings release can be viewed as well as on the company’s website at . Cerner will host an earnings conference call to provide additional detail on the Company’s results a...

 PRESS RELEASE

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcome...

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcomes Combining decades of healthcare, life sciences and collaborative research to transform the way care is delivered KANSAS CITY, Mo., Oct. 26, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, announces the launch of a new operating unit, SM, that offers data-driven solutions and research services to help bring clarity to multi-dimensional data through real-world evidence and insights. The combined expertise of the Cerner and Kantar Health teams is expected to help accelerate discovery, ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch